Publicaciones en colaboración con investigadores/as de Sociedad Española de Reumatología (18)

2022

  1. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

    Reumatologia Clinica, Vol. 18, Núm. 10, pp. 567-573

  2. Tele-Rheumatology During the COVID-19 Pandemic

    Reumatologia Clinica, Vol. 18, Núm. 3, pp. 157-163

  3. Usefulness of Rheumatology Consultancy in situ: Analysis of a Long-term Experience

    Reumatologia Clinica, Vol. 18, Núm. 8, pp. 480-485

2021

  1. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up

    Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2906-2915

2019

  1. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project

    Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 731-739

  2. Methotrexate in patients with rheumatoid arthritis in Spain: Subanalysis of the AR Excellence project

    Reumatologia Clinica, Vol. 15, Núm. 6, pp. 338-342

2017

  1. Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort

    Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942

  2. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

  3. Recommendations by the Spanish Society of Rheumatology for the management of patients diagnosed with rheumatoid arthritis who cannot be treated with methotrexate

    Reumatologia Clinica, Vol. 13, Núm. 3, pp. 127-138

2016

  1. Differences between familial and sporadic early spondyloarthritis: Results from the ESPERANZA cohort

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 575-580

2015

  1. Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide

    Reumatologia Clinica, Vol. 11, Núm. 5, pp. 279-294

2011

  1. Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas

    Reumatologia Clinica, Vol. 7, Núm. 5, pp. 284-298

2010

  1. Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis

    Reumatologia Clinica, Vol. 6, Núm. 1, pp. 23-36

2009

  1. Characteristics of Paget's disease in Spain. Data from the National Paget's Register

    Reumatologia Clinica, Vol. 5, Núm. 3, pp. 109-114

2008

  1. Prevalence of Paget's disease of bone in Spain

    Bone, Vol. 43, Núm. 6, pp. 1006-1009

2007

  1. Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas (BIOBADASER): Informe de la situación, 26 de enero de 2006

    Reumatologia Clinica, Vol. 3, Núm. 1, pp. 4-20

2006

  1. Consensus document of the Spanish Society of Rheumatology on fibromyalgia

    Reumatologia Clinica, Vol. 2, Núm. SPEC. ISS. 1, pp. 55-66

2001

  1. Sociedad Española de reumatología. Uso de coxibs

    Revista Espanola de Reumatologia, Vol. 28, Núm. 8, pp. 341-342